Que es sindrome de supresion aguda de los corticosteroides

A total of 5380 patients underwent randomization and were followed for up to 40 months (median, 18 months). A primary end-point event occurred in 305 patients assigned to alogliptin (%) and in 316 patients assigned to placebo (%) (hazard ratio, ; upper boundary of the one-sided repeated confidence interval, ; P< for noninferiority). Glycated hemoglobin levels were significantly lower with alogliptin than with placebo (mean difference, - percentage points; P<). Incidences of hypoglycemia, cancer, pancreatitis, and initiation of dialysis were similar with alogliptin and placebo.

Que es sindrome de supresion aguda de los corticosteroides

que es sindrome de supresion aguda de los corticosteroides

Media:

que es sindrome de supresion aguda de los corticosteroidesque es sindrome de supresion aguda de los corticosteroidesque es sindrome de supresion aguda de los corticosteroidesque es sindrome de supresion aguda de los corticosteroidesque es sindrome de supresion aguda de los corticosteroides

http://buy-steroids.org